Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68572M106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
RTW Investments, LP
13D/A
Amendment 7
|
19.2% |
4/29/2026
Event 4/27/2026
|
|
| RTW Investments, LP | 19.2% | ||
| RTW Master Fund, Ltd. | 9.6% | ||
| RTW Innovation Master Fund, Ltd. | 8.1% | ||
| Roderick Wong | 19.2% | ||
|
Medtronic plc
13G/A
Amendment 3
|
17.8% |
2/27/2026
Event 12/31/2025
|
|
| Medtronic plc | 17.8% | ||
| Covidien Group S.a.r.l. | 17.8% | ||
|
RTW Investments, LP
13D/A
Amendment 6
|
19.7% |
2/25/2026
Event 2/23/2026
|
|
| RTW Investments, LP | 19.7% | ||
| RTW Master Fund, Ltd. | 10.0% | ||
| RTW Innovation Master Fund, Ltd. | 8.4% | ||
| Roderick Wong | 19.7% | ||
|
Tasso Partners, LLC
13G
|
5.5% |
11/19/2025
Event 11/15/2025
|
|
| Tasso Partners, LLC | 5.0% | ||
| Dana Lorenzo | 5.5% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 3
|
10.0% |
11/14/2025
Event 9/30/2025
|
|
| Perceptive Advisors LLC | 10.0% | ||
| Joseph Edelman | 10.0% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | ||
|
RTW Investments, LP
13D/A
Amendment 5
|
15.4% |
8/6/2025
Event 8/4/2025
|
|
| RTW Investments, LP | 15.4% | ||
| RTW Master Fund, Ltd. | 8.1% | ||
| RTW Innovation Master Fund, Ltd. | 5.7% | ||
| Roderick Wong | 15.4% | ||
|
RTW Investments, LP
13D/A
Amendment 4
|
21.7% |
5/1/2025
Event 4/29/2025
|
|
| RTW Investments, LP | 21.7% | ||
| RTW Master Fund, Ltd. | 11.5% | ||
| RTW Innovation Master Fund, Ltd. | 8.0% | ||
| Roderick Wong, M.D. | 21.7% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 3.7% |
4/29/2025
Event 3/31/2025
|
|
|
Medtronic plc
13G/A
Amendment 2
|
15.4% |
2/14/2025
Event 12/31/2024
|
|
| Medtronic plc | 15.4% | ||
| Covidien Group S.a.r.l. | 15.4% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 438 | $2.72 k |
| 2026 Q2 | 81 | 27.7 M | $120 M |
| 2026 Q1 | 66 | 23.1 M | $98.2 M |
| 2025 Q4 | 66 | 21.7 M | $90.1 M |
| 2025 Q3 | 54 | 22.9 M | $56.1 M |
| 2025 Q2 | 61 | 18.1 M | $47.6 M |
| 2025 Q1 | 57 | 19.0 M | $81.3 M |
| 2024 Q4 | 55 | 19.3 M | $77.0 M |
| 2024 Q3 | 50 | 19.0 M | $97.8 M |
| 2024 Q2 | 50 | 14.3 M | $116 M |
| 2024 Q1 | 47 | 13.4 M | $70.5 M |
| 2023 Q4 | 42 | 13.3 M | $121 M |
| 2023 Q3 | 43 | 13.1 M | $114 M |
| 2023 Q2 | 41 | 10.8 M | $75.5 M |
| 2023 Q1 | 22 | 9.87 M | $193 M |
| 2022 Q4 | 1 | 686 k | $6.85 M |